Phenothiazine analgesia--fact or fantasy?

Area of Science:

• Pharmacology
• Clinical Medicine
• Pain Management

Background:

• Phenothiazines are a class of drugs with diverse applications.
• Their potential use as analgesics or to enhance pain relief has been investigated.
• Adverse effects associated with phenothiazine use require careful consideration.

Purpose of the Study:

• To review and evaluate double-blind clinical trials on phenothiazines as analgesics or potentiators of analgesics.
• To assess the adverse effects of phenothiazines in the context of pain management.
• To determine the efficacy and safety of phenothiazines for pain relief and antiemesis.

Main Methods:

• Systematic review and evaluation of double-blind clinical trials.
• Analysis of studies investigating phenothiazines (promethazine, promazine, propiomazine, chlorpromazine, methotrimeprazine) for analgesic properties.
• Assessment of reported adverse reactions compared to narcotic analgesics.

Main Results:

• Promethazine, promazine, and propiomazine showed no analgesic or potentiating properties.
• Chlorpromazine studies had significant design flaws, preventing recommendations for pain treatment.
• Methotrimeprazine demonstrated some analgesic properties, but studies were often deficient.
• Adverse reactions (hypotension, sedation, extrapyramidal symptoms, tardive dyskinesia, cardiac toxicity, agranulocytosis) were common and severe.
• Prophylactic use for narcotic analgesic-induced emesis is questionable.

Conclusions:

• Lack of robust data supporting analgesic activity for phenothiazines.
• Significant adverse effects outweigh potential benefits in pain management.
• Use of phenothiazines for pain relief and routine antiemesis prevention is discouraged.